Trends in thrombolytic use for ischemic stroke in the United States. - Wikidata - awgldk - TriplyDB

Trends in thrombolytic use for ischemic stroke in the United States.

Trends in thrombolytic use for ischemic stroke in the United States.

http://www.wikidata.org/entity/Q34508464

about

How can we improve stroke thrombolysis rates? A review of health system factors and approaches associated with thrombolysis administration rates in acute stroke care Motor System Reorganization After Stroke: Stimulating and Training Toward Perfection Imaging of prehospital stroke therapeutics Isoflurane postconditioning induces neuroprotection via Akt activation and attenuation of increased mitochondrial membrane permeability Thrombolysis ImPlementation in Stroke (TIPS): evaluating the effectiveness of a strategy to increase the adoption of best evidence practice--protocol for a cluster randomised controlled trial in acute stroke care.Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.Effect of the Pleiotropic Drug CNB-001 on Tissue Plasminogen Activator (tPA) Protease Activity in vitro: Support for Combination Therapy to Treat Acute Ischemic Stroke.The neuroprotective properties of the superoxide dismutase mimetic tempol correlate with its ability to reduce pathological glutamate release in a rodent model of stroke.Emerging Therapies: Pleiotropic Multi-target Drugs to Treat Stroke Victims Outcomes after acute ischemic stroke in the United States: does residential ZIP code matter?Signaling via the prostaglandin E₂ receptor EP4 exerts neuronal and vascular protection in a mouse model of cerebral ischemia.Agreement with evidence for tissue Plasminogen Activator use among emergency physicians: a cross-sectional survey Intravenous Recombinant Tissue Plasminogen Activator Does Not Impact Mortality in Acute Ischemic Stroke at Any Time Point up to 6 Months: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.Increase in national intravenous thrombolysis rates for ischaemic stroke between 2005 and 2012: is bigger better?Critical early thrombolytic and endovascular reperfusion therapy for acute ischemic stroke victims: a call for adjunct neuroprotection.Early stroke mortality, patient preferences, and the withdrawal of care bias.Mesenchymal Stromal Cells Promote Axonal Outgrowth Alone and Synergistically with Astrocytes via tPA Why don't more patients receive intravenous rt-PA for acute stroke?RIGOR guidelines: escalating STAIR and STEPS for effective translational research Drug-like property profiling of novel neuroprotective compounds to treat acute ischemic stroke: guidelines to develop pleiotropic molecules Maximizing efficiency and diagnostic accuracy triage of acute stroke patients: A case-control study.Use of intravenous tissue plasminogen activator and hospital costs for patients with acute ischaemic stroke aged 18-64 years in the USA.Fast neuroprotection (fast-NPRX) for acute ischemic stroke victims: the time for treatment is now.The role of astrocytes in mediating exogenous cell-based restorative therapy for stroke Tissue plasminogen activator; identifying major barriers related to intravenous injection in ischemic acute cerebral infraction.Development of transcranial sonothrombolysis as an alternative stroke therapy: incremental scientific advances toward overcoming substantial barriers.Improving acute stroke management with computed tomography perfusion: a review of imaging basics and applications.Clinical trials in acute ischemic stroke.Astrocytes, therapeutic targets for neuroprotection and neurorestoration in ischemic stroke.The High Cost of Stroke and Stroke Cytoprotection Research.Residential zip code influences outcomes following hospitalization for acute pulmonary embolism in the United States.Explicit consideration of baseline factors to assess recombinant tissue-type plasminogen activator response with respect to race and sex Regulatory CD8(+)CD122 (+) T-cells predominate in CNS after treatment of experimental stroke in male mice with IL-10-secreting B-cells.Rate of intravenous thrombolysis for acute ischaemic stroke in the North-of-France region and evolution over time.Socioeconomic disparities in the utilization of mechanical thrombectomy for acute ischemic stroke in US hospitals.Novel Telestroke Program Improves Thrombolysis for Acute Stroke Across 21 Hospitals of an Integrated Healthcare System.Cytoprotective Drug-Tissue Plasminogen Activator Protease Interaction Assays: Screening of Two Novel Cytoprotective Chromones.Factors associated with late arrival of acute stroke patients to emergency department in Saudi Arabia.

P2860

Q26750590-7094DD15-5CC4-429D-8D15-DCD5EA8E90E3 Q26795480-0CD925B1-68EA-4137-B41E-E8D601617D1B Q26797275-48441FDA-C2A0-46EC-A403-CDC79746F184 Q30423236-13DD4DDC-CD69-4FC0-8B17-EEF8C7744A2F Q33593063-28A91204-2204-4C74-AE35-41FD08CF3EB0 Q34015715-93EFC1CF-8C32-42BE-9402-5DB9997C6326 Q34432486-531A8C78-F903-4409-B3FD-27EBEABF405F Q34647344-967BBE05-85E3-431C-AEA6-D8599CBC8481 Q35029799-48D795D1-791F-4F19-8490-6249D6F4727C Q35354199-1850828A-BD4A-484C-A30E-F8DA58EC22B5 Q35484819-4CBD1860-8B03-453D-A91A-C9AF0B088B3F Q35674774-2551DC46-709B-4266-A613-8540BE0431B0 Q35739435-26CCEF95-CEAE-4AD9-9FF8-95D0EB8863FB Q35996684-DC83A740-AF70-4AF9-9FD8-71F306F8B43C Q36056147-73D3AE53-0240-4629-B98C-DB5ACCAF3F56 Q36183826-EF24C190-A9E1-409E-80BA-87000FF9E07E Q36222296-81175D67-7FE5-4ACC-BD54-1FE4DD85D37A Q36794959-A6F5EF09-1730-4CA9-980E-1A656A31F75E Q36816551-4F4FA981-A6DD-4DB7-B8A8-D0087CDE3916 Q36841904-8751A846-15B9-44B1-9D02-ABCA002A3E7B Q37173834-54B475C1-6688-4927-B078-5842FC96BFB5 Q37187432-4A24A034-391A-4267-9CAC-344026024DBE Q37420266-C5F402BC-9A66-49A0-8840-C19FAC23A12F Q37627332-4382452B-1EB8-414C-A08F-475B7A07AFCA Q37721912-1305B175-3B4F-4201-AEBE-B846150F74F6 Q38088270-DA5D6248-7666-4CC8-87FF-C53F4E11EC59 Q38170056-D41F8295-A1F4-462F-ABF3-E4F9F4BC391A Q38243696-4FD041BB-9A82-40B0-813C-F0795F9A32EF Q38603996-EA35A478-A273-49D7-812F-3223CAB3CEFF Q38776049-F3BBB84F-FACF-43F9-AB37-B42933F41E84 Q40749413-CA67753D-E8F5-4425-8700-6F732B755FE3 Q41174235-EC2C5EE3-1386-4115-85F6-1E2E92302ECF Q42404553-53B48FE9-8936-4243-A489-7855712813DA Q46073638-9BE0E0BF-D580-41AB-8950-64DCF2BF3762 Q49159786-C5430652-CB04-4B0A-BD5E-43EECE3C7985 Q49689017-C7ADE267-788A-4733-B3E0-4E2224ADC21A Q53359412-B46FAC73-036E-466E-B0C7-FEB66A5BAB60 Q55044965-0D1C2A35-F65E-4A4D-8BB9-EF13388A150F

P2860

Trends in thrombolytic use for ischemic stroke in the United States.

http://www.wikidata.org/entity/Q34508464

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Trends in thrombolytic use for ischemic stroke in the United States.

@ast

Trends in thrombolytic use for ischemic stroke in the United States.

@en

Trends in thrombolytic use for ischemic stroke in the United States.

@nl

type

label

Trends in thrombolytic use for ischemic stroke in the United States.

@ast

Trends in thrombolytic use for ischemic stroke in the United States.

@en

Trends in thrombolytic use for ischemic stroke in the United States.

@nl

prefLabel

Trends in thrombolytic use for ischemic stroke in the United States.

@ast

Trends in thrombolytic use for ischemic stroke in the United States.

@en

Trends in thrombolytic use for ischemic stroke in the United States.

@nl

P1433

Q34508464-0475C5E1-EFF3-4101-9944-3E3C3D7E5375

P1476

Q34508464-23D2B7DB-9297-4F5D-9950-6BCE1DA3C26C

P2093

Q34508464-456D7132-1A2D-454C-A073-4262C7D9E40C

Q34508464-463D1201-E85A-41AF-BE51-5864A4B575FA

Q34508464-B08D96E0-9DA7-4392-9B92-363DD105D2E6

P2860

Q34508464-0111FAE7-1A93-4C04-B532-A95EEDB9EEB5

Q34508464-07211301-B7D8-411D-827B-5196A8D99489

Q34508464-092EC51F-A5D8-4D72-B046-60E2CAA38ACC

Q34508464-0BD1AD77-698C-40B7-8993-18AF6FF117BA

Q34508464-1279E011-7EF6-4DB7-8E3F-0CAEEDCC1D61

Q34508464-1A254F66-E182-428D-95C6-BE30F619DF98

Q34508464-1D31F6FC-3B2D-444D-A6E2-034D29363DE3

Q34508464-22EADA90-8989-45F4-8471-4F28D9C434F7

Q34508464-3D207A0B-58A9-448B-BBDC-7D73F75E877E

Q34508464-6487F7D6-3E38-472C-8D8C-8B5E6B5D9EF7

P304

Q34508464-EB3EC42D-92F0-44C9-A286-9959EAD65994

P31

Q34508464-496A04B3-24AB-4667-AB63-DE04DF312B38

P356

Q34508464-A288EA35-E191-4109-BB52-BEF82CCB2546

P433

Q34508464-947526B7-706E-4466-A05E-40727744162D

P478

Q34508464-5B0AEC0D-F3B8-46E8-955B-5BDA435143DC

P577

Q34508464-260F14ED-FC3A-4E5D-BB21-0C85C6125492

P5875

Q34508464-287EF364-C347-4323-B93B-90AFE7F923B9

P698

Q34508464-7894A47D-5FE7-41E4-BDA0-93A821748C25

P921

Q34508464-091345AB-1D0E-4709-8548-E29DBC52E95E

Q34508464-B5A4A06A-04F3-4112-82B4-3F9CF6547459

P932

Q34508464-D7D4B04A-8084-45EB-A1AA-B1B807FDF178

P356

P1433

Journal of Hospital Medicine

P1476

Trends in thrombolytic use for ischemic stroke in the United States.

@en

P2093

Allison B Rosen

http://www.w3.org/2001/XMLSchema#string

David M Cutler

http://www.w3.org/2001/XMLSchema#string

Margaret C Fang

http://www.w3.org/2001/XMLSchema#string

P2860

Tissue plasminogen activator for acute ischemic stroke

Thrombolysis for ischemic stroke in the United States: data from National Hospital Discharge Survey 1999-2001.

Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data.

Recommendations for the establishment of primary stroke centers. Brain Attack Coalition.

Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centers: the influence of ethnicity.

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000.

Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the A

Stroke severity in atrial fibrillation. The Framingham Study.

Management of acute ischaemic stroke: new guidelines from the American Stroke Association and European Stroke Initiative.

P304

406-409

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JHM.689

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44800047

http://www.w3.org/2001/XMLSchema#string

P698

20578049

http://www.w3.org/2001/XMLSchema#string

P921

Ameeriga Ütisriigiq

P932

3024589

http://www.w3.org/2001/XMLSchema#string